Malignant gliomas in children

Cancer Investigation

Volumn 14, Issue 6, 1996, Pages 609-621

  Johnson Jr , James H ^a,b   Phillips, Peter C ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; GLIOMA; HISTOLOGY; HUMAN; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY;

EID: 0030445104     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609076905     Document Type: Review

References (72)

1. Young JL Jr, Ries LG, Silberberg E, et al: Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 58:598-602, 1986.
2. Duffner PK, Cohen ME, Myers MH, et al: Survival of children with brain tumors: SEER program, 1975-1980. Neurology 36:597-601, 1986.
3. Childhood Brain Tumor Consortium: A study of childhood brain tumors based on neurosurgical biopsies from ten North American institutions, sample description. J Neuro-Oncol 6:9-23, 1988.
4. Borst M: Die Lehre von den Geschwulsten. Wiesbaden, Bergmann, 1902.
5. Bailey C, Cushing H: Classification of Tumors of the Glioma Group on a Histogenic Basis with a Correlated Study of Prognosis. Philadelphia, J B Lippincott, 1926.
6. Kernohan JW, Mahon RF, Svien HJ, et al: A simple classification of gliomas. Proc Staff Meet Mayo Clin 24:875, 1949.
7. Kernohan JW, Sayre D: Armed Forces Institute of Pathology, Sect 10, fascicle, Vol 35 and 37, 1952, pp 7-129.
8. Zulch KJ, Mennel HD: The biology of brain tumors. In: Handbook of Clinical Neurology, Vol 16, edited by PJ Vinken, GW Bryun. New York, American Elsevier, 1974, pp 1-55.
9. Burger PC, Green SB: Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59:1617-1625, 1987.
10. Ringertz N: Grading of gliomas. Acta Pathol Microbiol Scand 27:51-64, 1953.
11. Burger PC, Vogel FS: Surgical Pathology of the Nervous System and Its Coverings. New York, Wiley, 1982, pp 226-266.
12. Zulch KJ: Histological Typing of Tumours of the Central Nervous System, International Classification of Tumours, number 21. Geneva, World Health Organization, 1979.
13. Daumas-Duport C, Scheithauer B, O'Fallon J, et al: Grading of astrocytomas, a simple and reproducible method. Cancer 62:2152-2165, 1988.
14. Takahashi T, Nowkowski RS, Caviness VS Jr: Mode of cell proliferation in the developing mouse neocortex. Proc Natl Acad Sci USA 91:375-379, 1994.
15. Burger PC, Vollmer RT: Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer 46:1179-1186, 1980.
16. Nelson JS, Tsudaka Y, Schoenfeld D, et al: Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 52:550-554, 1983.
17. Barnard RO, Geddes JF: The incidence of multifocal cerebral gliomas, a histologic study of large hemisphere sections. Cancer 60:1519-1531, 1987.
18. Burger PC, Heinz ER, Shibata T, et al: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68:698-704, 1988.
19. Hoshino T, Prados M, Wilson CB, et al: Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. J Neurosurg 71:335-341, 1989.
20. Hoshino T, Ito S, Asai A, et al: Cell kinetic analysis of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine. Int J Cancer 50:1-5, 1992.
21. Olopade OI, Jenkins RB, Ransom DT, et al: Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 53:2523-2529, 1992.
22. Sidransky D, Mikkelsen T, Schwechheimer K, et al: Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355:846-847, 1992.
23. James CD, Carlborn E, Dumanski JP, et al: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546-5551, 1988.
24. Von Deimling A, Louis DN, Von Ammon K, et al: Evidence for a tumor gene on chromosome 19q associated with astrocytomas, oligodendrogliomas and mixed gliomas. Cancer Res 52:4277-4279, 1992.
25. Griffin CA, Hawkins AL, Packer RJ: Chromosome abnormalities in pediatric brain and spinal cord tumors. Pediatr Neurosurg 17:57-65, 1991-92.
26. Chadduck WM, Boop FA, Sawyer JR: Cytogenetic studies of pediatric brain and spinal cord tumors. Pediatr Neurosurg 17:57-65, 1991-91
27. Karnes PS, Tran TN, Cui MY: Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genet Cytogenet 59:12-19, 1992.
28. Neumann E, Kalousek DK, Norman MG: Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet 71:40-49, 1993.
29. Wasson JC, Saylors RL III, Zeltzer P, et al: Oncogene amplification in pediatric brain tumors. Cancer Res 50:2987-2990, 1990.
30. Litotsky NS, Hinton D, Raffel C: The lack of a role for p53 in astrocytomas in pediatric patients. Neurosurgery 34:967-973, 1994.
31. Rasheed BK, McLendon RE, Herndon JE: Alterations of the TP53 gene in human gliomas. Cancer Res 54:1324-1330, 1994.
32. U HS, Kelley PY, Hatton JD: Proto-oncogene abnormalities and their relationship to tumorigenicity in some human glioblastomas. J Neurosurg 71:83-90, 1989.
33. Henson JW, Schnitker BL, Correa KM: The retinoblastoma gene is involved in malignant progression of astrocytomas. Neurology 36:714-721, 1994.
34. Jelsma R, Bucy PC: The treatment of glioblastoma multiforme of the brain. J Neurosurg 27:388-400, 1967.
35. Dohrmann GJ, Farwell JR, Flannery JT: Glioblastoma multiforme in children. J Neurosurg 44:442-448, 1976.
36. Backus RE, Millichap JG: The seizure as a manifestation of intracranial astrocytomas and oligodendrogliomas. Pediatrics 29:978-984, 1962.
37. Ajmone-Marson C, Zivin LS: Factors related to the occurrence of typical paroxysmal abnormalities in the EEG record of epileptic patients. Epilepsia 11:361-381, 1970.
38. Mansfield P, Morris PG. NMR Imaging in Biomedicine. New York, Academic Press, 1982.
39. Balaban RS, Ceckler TL: Magnetization transfer contrast in magnetic resonance imaging. Magnet Reson Q 8:116-137, 1992.
40. Detre JA, Zhang W, Roberts DA: Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed 7:75-82, 1994.
41. Ebisu T, Naruse S, Horikawa Y: The application of in vivo diffusion weighted magnetic resonance imaging to intracranial disorders. No to Shinkei-Brain Nerve 43:677-684, 1991.
42. Sutton LN, Lenkinski RE, Cohen BH, et al: Localized 31P magnetic resonance spectroscopy of large pediatric brain tumors. J Neurosurg 72:65-70, 1990.
43. Sutton LN, Wang Z, Gusnard D, et al: Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 31:195-202, 1992.
44. O'Tuama KA, Phillips PC, Strauss LC, et al: Two phase [11C]L-methionine PET scanning in diagnosis of childhood brain tumors. Pediatr Neurol 6:163-170, 1990.
45. Davis WK, Boyko OB, Hoffman JM, et al: [18F]2-Fluoro-2-deoxy-glucose-positron emission tomography, correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. Am J Neuroradiol 14:515-523, 1993.
46. Alavi JB, Alavi A, Chawluk J, et al: Positron emission tomography in patients with glioma. Cancer 62:1074-1078, 1988.
47. Kandt RS, Shinnar S, D'Souza BJ, et al: Cerebrospinal metastases in malignant childhood astrocytomas. J Neuro-Oncol 2:123-128, 1984.
48. Packer RJ, Siegel KR, Sutton LN, et al: Leptomeningeal dissemination of primary central nervous system tumors of childhood. Ann Neurol 18:217-221, 1985.
49. Grabb PA, Albright AL, Pang D: Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery 30:64-71, 1992.
50. Balhuizen JC, Bots GTAM, Schaberg A, et al: Value of cerebrospinal fluid cytology for the diagnosis of malignancies in the central nervous system. J Neurosurg 48:747-753, 1978.
51. Moser RP: Surgery for glioma relapse. Cancer 62:381-390, 1988.
52. Seaward S, Goldwein J, Needle M, et al: Malignant gliomas in children: patterns of presentation, treatment and prognostic factors. Sixth International Symposium in Pediatric Neuro-Oncology, 1994, abstract.
53. Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73:331-344, 1990.
54. Golfinos JG, Joy M, Goldenberg A, et al: Computer and robot assisted resection of thalamic astrocytomas in children. J Neurosurg 83:197-205, 1995.
55. Walker MD, Gehan EA: Clinical studies in malignant gliomas and their treatment with the nitrosoureas. Cancer Treat Rep 60:713-716,1976.
56. Phuphanich S, Edwards MS, Levin VA: Supratentorial malignant gliomas of childhood: Result of treatment with radiation therapy and chemotherapy. J Neurosurg 60:495-499, 1984.
57. Payne DG, Simpson WJ, Keen C, et al: Malignant astrocytoma, hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial. Cancer 50:2301-2306, 1982.
58. Black PM, Tarbell NJ, Alexander E III: Stereotactic techniques in managing pediatric brain tumors. Child Nerv Syst 9:343-346, 1993.
59. Loeffler JS, Alexander E III, Hochberg FH: Clinical patterns of failure following stereotactic interstitial radiation for malignant gliomas. Int J Radial Oncol 19:1455-1462, 1990.
60. Loeffler JS, Alexander E III, Wen PY: Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J National Cancer Inst 82:1918-1921, 1990.
61. Bernstein M, Laperriere NJ: A critical appraisal of the role of brachytherapy for pediatric brain tumors. Pediatr Neurosurg 16:213-218, 1990-91.
62. Leibel SA, Gutin PH, Wara WM: Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17:1129-1139, 1989.
63. Shrieve DC, Tarbell NJ, Alexander E III, et al: Stereotaclic radiotherapy: A technique for close optimization and escalation for intracranial tumors. Acta Neurochur 62(Suppl):118-123, 1994.
64. Webb S: The effect on tumor control probability of varying the setting of a multileaf collimator with respect to the planning target volume. Phys Med Biol 38:1923-1936, 1993.
65. Shapiro WR, Green SB, Burger PC: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. J Neurosurg 71:1-9, 1989.
66. Levin VA, Wara WM, Davis RL: Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. J Neurosurg 63:218-223, 1985.
67. Sposto R, Ertel IJ, Jenkin RDT: The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial, a report from the Childrens Cancer Study Group. J Neuro-Oncol 7:165-177, 1989.
68. Pendergrass TW, Milstein JM, Geyer JR, et al: Eight drugs in one day chemotherapy for brain tumors: Experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol 5:1221-1231, 1987.
69. Finlay JL, Boyett JM, Yates AJ, et al: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine and prednisone with eight-drugs-in-one-day regimen. J Clin Oncol 13:112-123, 1995.
70. Duffner PD, Horowitz ME, Krischer JP: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725-1731, 1993.
71. Finlay JL, August C, Packer R, et al: High-dose multi-agent chemotherapy followed by bone marrow "rescue" for malignant astrocytomas of childhood and adolescence. J Neuro-Oncol 9:239-248, 1990.
72. Heideman RL, Douglass BC, Krance RA, et al: High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol 11:1439-1440, 1993.